Metabolic / Weight
Tirzepatide 30mg
$59.49
$84.99
A dual GIP and GLP-1 receptor agonist — the “twincretin” that engages two incretin pathways simultaneously. Widely studied for metabolic regulation, glucose handling, and body-composition research. A single-chain 39-amino-acid peptide bearing a C20 fatty-diacid moiety for extended action.
Purity ≥99% · Research Purposes Only
Pre-sale item — ships in 2–3 weeks.
Purity
≥ 99% (HPLC)
Form
Lyophilized Powder
Storage
-20°C, protect from light
Molecular Weight
Varies by compound
COA
Included with order
Tirzepatide
$59.49
Certificate of Analysis
Independent third-party testing by Janoshik Laboratory
Janoshik Certified
99.846%
Purity
Test Results
| Tirzepatide | 32.51 mg |
| Purity | 99.846% |
| Heavy Metals | Not Detected |
| Sterility | No Growth |
Certificate of Analysis
Verified by Janoshik Laboratory
Compound Information
Technical specifications & storage requirements
Molecular Profile
What Is Tirzepatide?
A single-chain 39-amino-acid synthetic peptide bearing a C20 fatty-diacid moiety for albumin binding and extended action. Engages both the GIP and GLP-1 incretin receptors in a single molecule.
Classification
Dual GIP / GLP-1 Receptor Agonist ("Twincretin")
CAS Number
2023788-19-2
Molecular Weight
4,813.45 g/mol
Amino Acids
39
Form
Lyophilized Powder
Purity
≥ 99% (HPLC Verified)
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C
24+ months
Reconstituted
2–8°C
~30 days
For in vitro research and laboratory use only. Not for human or veterinary consumption.
Sources & References
Peer-reviewed research
NEW ENGLAND JOURNAL OF MEDICINE
Tirzepatide versus semaglutide once weekly in adults with type 2 diabetes (SURPASS-2)
View Source NEW ENGLAND JOURNAL OF MEDICINE
Once-weekly tirzepatide for the treatment of obesity (SURMOUNT-1)
View Source THE LANCET
Dual GIP and GLP-1 receptor agonism with tirzepatide in type 2 diabetes (SURPASS-1)
View Source